Femme et Homme
- | Pays :
- Switzerland
- Germany
- | Organes : -
- | Spécialités : -
Extrait
This study is designed to develop our understanding of the efficacy and safety of using lumiracoxib in the treatment of patients with acute gout. This is a multi-center, double-blind, randomized, parallel group study comparing a single daily dose of 400 mg lumiracoxib with the established dose of indomethacin 50 mg taken three times a day in terms of efficacy
Critère d'inclusion
- Acute Gouty Arthritis